MEDANTA
NIFTY500
Global Health Ltd.
Pharma · NSE
₹1,200.60
1Y-0.6%
52-week range
₹956 – ₹1,456
From 52w high
-17.5%
RSI (14)
67.3
vs SMA 50 / 200
↑ 50 · ↓ 200
PE
64.9
Forward PE
47.8
ROE
—
Profit margin
12.3%
D/E
25.47
Dividend yield
0.04%
Quality score
29/100
Revenue growth
18.8%
Earnings growth
-33.5%
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.